Apoptotic effect of dibenzylideneacetone on oral cancer cells via modulation of specificity protein 1 and Bax
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apoptotic effect of dibenzylideneacetone on oral cancer cells via modulation of specificity protein 1 and Bax
Authors
Keywords
-
Journal
ORAL DISEASES
Volume 19, Issue 8, Pages 767-774
Publisher
Wiley
Online
2012-12-28
DOI
10.1111/odi.12062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RETRACTED: Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: Role of Michael acceptors and Michael donors
- (2011) Preetha Anand et al. BIOCHEMICAL PHARMACOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1
- (2011) Eun-Sun Choi et al. CANCER SCIENCE
- Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways
- (2011) S. Prakobwong et al. CARCINOGENESIS
- A Novel Monocarbonyl Analogue of Curcumin, (1E,4E)-1,5-Bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, Induced Cancer Cell H460 Apoptosis via Activation of Endoplasmic Reticulum Stress Signaling Pathway
- (2011) Yi Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting SP1 Transcription Factor in Prostate Cancer Therapy
- (2011) Umesh T. Sankpal et al. Medicinal Chemistry
- The role of Sp1 and Sp3 in normal and cancer cell biology
- (2010) Lin Li et al. ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
- Cancer risks from betel quid chewing beyond oral cancer: a multiple-site carcinogen when acting with smoking
- (2010) Chi Pang Wen et al. CANCER CAUSES & CONTROL
- ROS and CHOP Are Critical for Dibenzylideneacetone to Sensitize Tumor Cells to TRAIL through Induction of Death Receptors and Downregulation of Cell Survival Proteins
- (2010) Sahdeo Prasad et al. CANCER RESEARCH
- Chemopreventive effect of tolfenamic acid on KB human cervical cancer cells and tumor xenograft by downregulating specificity protein 1
- (2010) Jung-Hyun Shim et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis
- (2010) Suksanti Prakobwong et al. INTERNATIONAL JOURNAL OF CANCER
- Apoptotic effect of Polygonum Cuspidatum in oral cancer cells through the regulation of specificity protein 1
- (2010) J-A Shin et al. ORAL DISEASES
- Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice
- (2009) Jimmie Colon et al. INVESTIGATIONAL NEW DRUGS
- Sp1 Phosphorylation and Its Regulation of Gene Transcription
- (2009) N. Y. Tan et al. MOLECULAR AND CELLULAR BIOLOGY
- p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter
- (2008) Maciej Pietrzak et al. BIOLOGICAL CHEMISTRY
- Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma
- (2008) N. Y. Jiang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
- (2008) G. Chadalapaka et al. CANCER RESEARCH
- Tris (Dibenzylideneacetone) Dipalladium, a N-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth In vitro and In vivo
- (2008) S. S. Bhandarkar et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More